assessing the role of 21-gene assays in breast cancer
Published 5 years ago • 183 plays • Length 0:40Download video MP4
Download video MP3
Similar videos
-
5:54
roxane: impact of 21-gene assay on treatment for early breast cancer
-
5:34
tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
-
2:34
genomic assays impact treatment decisions in patients with er breast cancer
-
58:32
molecular testing in breast cancer: will it become standard practice?
-
18:14
does 21-gene recurrence score assay testingchange decisions? dr. adher alsayed ( day 1)
-
58:26
molecular testing in breast cancer: will it become standard practice? - kimberly allison, md
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
14:37
genomic testing in breast cancer: what you must know
-
22:28
eric winer: the role of the 21 gene recurrence score in decision making for er breast cancer
-
55:51
her2 testing in breast cancer: improving ihc performance
-
4:54
role of the oncotype dx breast recurrence score test
-
13:05
molecular characterization via the 21-gene breast recurrence score assay of mbrca1/2 patients.
-
55:33
personalized medicine: the role of testing in metastatic breast cancer
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
5:24
oncotype dx – do i need a breast cancer gene-expression assay?
-
1:13:21
clinical outcomes in early breast cancer with a high 21-gene recurrence score tailorx rct
-
8:29
approaching her2 testing in breast cancer
-
6:31
ah-ha moment leads to new breast cancer tumor testing standards - mayo clinic
-
23:51
2022 west oncology conference | precision oncology in hr breast cancer